Business Description
Clinomics Inc
ISIN : KR7352770002
Share Class Description:
XKRX:352770: Ordinary SharesCompare
Compare
Traded in other countries / regions
352770.Korea IPO Date
2020-12-03Description
Clinomics Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.54 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.8 | |||||
Beneish M-Score | -4.45 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.3 | |||||
3-Year EBITDA Growth Rate | -32.7 | |||||
3-Year EPS without NRI Growth Rate | -27.6 | |||||
3-Year FCF Growth Rate | 11.7 | |||||
3-Year Book Growth Rate | -10.4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.78 | |||||
9-Day RSI | 28.56 | |||||
14-Day RSI | 32.45 | |||||
6-1 Month Momentum % | -24.06 | |||||
12-1 Month Momentum % | -39.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 111.11 | |||||
Days Sales Outstanding | 271.88 | |||||
Days Payable | 25.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -5.96 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.99 | |||||
Operating Margin % | -332.7 | |||||
Net Margin % | -398.72 | |||||
FCF Margin % | -105.87 | |||||
ROE % | -87.64 | |||||
ROA % | -42.91 | |||||
ROIC % | -35.85 | |||||
ROC (Joel Greenblatt) % | -111.95 | |||||
ROCE % | -64.64 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.76 | |||||
PB Ratio | 1.15 | |||||
Price-to-Tangible-Book | 1.34 | |||||
EV-to-EBIT | -1.69 | |||||
EV-to-EBITDA | -1.9 | |||||
EV-to-Revenue | 6.24 | |||||
EV-to-FCF | -5.82 | |||||
Earnings Yield (Greenblatt) % | -59.13 | |||||
FCF Yield % | -19.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clinomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 9,969.81 | ||
EPS (TTM) (â‚©) | -1585 | ||
Beta | 1.19 | ||
Volatility % | 55.51 | ||
14-Day RSI | 32.45 | ||
14-Day ATR (â‚©) | 112.453649 | ||
20-Day SMA (â‚©) | 1593.15 | ||
12-1 Month Momentum % | -39.17 | ||
52-Week Range (â‚©) | 1335 - 4200 | ||
Shares Outstanding (Mil) | 38.88 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clinomics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clinomics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Clinomics Inc Frequently Asked Questions
What is Clinomics Inc(XKRX:352770)'s stock price today?
The current price of XKRX:352770 is â‚©1393.00. The 52 week high of XKRX:352770 is â‚©4200.00 and 52 week low is â‚©1335.00.
When is next earnings date of Clinomics Inc(XKRX:352770)?
The next earnings date of Clinomics Inc(XKRX:352770) is .
Does Clinomics Inc(XKRX:352770) pay dividends? If so, how much?
Clinomics Inc(XKRX:352770) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |